The study is expected to begin in the first quarter of 2027 & enrol around 1,000 patients in Brazil, Malaysia & Thailand. SII ...

The non-profit Drugs for Neglected Diseases initiative (DNDi) has joined forces with pharma group Serum Institute of India ...

ICMR and Panacea Biotec conduct third phase trials for indigenous dengue vaccine in India with promising results.

In a phase 3 clinical trial, the tetravalent dengue vaccine, developed by the Butantan Institute in São Paulo, Brazil, was 80.5% effective against severe dengue cases with warning signs over a ...

Hoping to stem the global epidemic of Dengue, Panacea Biotec has begun final Phase III trials of its vaccine – Copyright AFP Arun SANKAR As dengue surges globally ...

A large-scale clinical trial to evaluate whether a candidate vaccine can prevent the mosquito-borne illness dengue fever has been launched in Brazil. The vaccine, TV003, was developed by scientists in ...

Malaysia, Thailand and Brazil will begin Phase III trials in 2027 for SII-DNDi's dengue antibody treatment. If successful, it ...

The Food and Drug Monitoring Agency (BPOM) said an mRNA-based dengue vaccine developed by the University of Indonesia and ...

New Delhi: There are a few dates in his life that Dr Syed Khalid Ali remembers as significant ones, and 14 August 2024 is one of them. It was the day the first participant from Rohtak, Haryana, was ...

The world's first single-dose vaccine to prevent dengue fever has been approved for licensure in one of the largest countries affected by the disease, following 16 years of research contributions by ...

Consultant Paediatrician and Founder Clinical Head of the Centre for Clinical Management of Dengue & Dengue Haemorrhagic Fever in Negombo, Dr. Lakkumar Fernando, said an internationally approved ...